Recombinant adeno-associated virus for muscle directed gene therapy
Krishna J. Fisher, Karin U. Jooss, James Alston et al. · Nature Medicine · 1997
Cited by 655 works. doi:10.1038/nm0397-306
Authors
- Krishna J. Fisher
- Karin U. Jooss
- Yiping Yang
- Sarah Ehlen Haecker
- Katherine A. High
- Ravindra Pathak
- Steven E. Raper
- James M. Wilson
References
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
- Direct Gene Transfer into Mouse Muscle in Vivo
- Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
- Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
- Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
- Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
- Adeno-associated virus general transduction vectors: analysis of proviral structures
- Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
- Site-specific integration by adeno-associated virus.